Open Insider Trading Activity for Cascadian Therapeutics, Inc. President and CEO Myers Scott Dunseth
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. CASC | 2017-08-14 | 2017-08-11 | Cascadian Therapeutics, Inc. | Myers Scott Dunseth | President and CEO | Buy | 1 | 5,500 | $3.74 | $20,570.00 | 11.06% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. CASC | 2017-05-16 | 2017-05-12 | Cascadian Therapeutics, Inc. | Myers Scott Dunseth | President and CEO | Buy | 1 | 2,800 | $4.00 | $11,200.00 | 6.33% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. CASC | 2017-04-04 | 2017-03-31 | Cascadian Therapeutics, Inc. | Myers Scott Dunseth | President and CEO | Buy | 1 | 2,000 | $4.11 | $8,220.00 | 4.83% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. CASC | 2017-03-21 | 2017-03-20 | Cascadian Therapeutics, Inc. | Myers Scott Dunseth | President and CEO | Buy | 1 | 1,000 | $3.93 | $3,930.00 | 2.54% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. CASC | 2017-01-31 | 2017-01-27 | Cascadian Therapeutics, Inc. | Myers Scott Dunseth | President and CEO | Buy | 1 | 20,500 | $3.76 | $77,080.00 | 53.36% | View Filing |
| Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. CASC | 2016-08-18 | 2016-08-17 | Cascadian Therapeutics, Inc. | Myers Scott Dunseth | President and CEO | Buy | 1 | 45,000 | $1.15 | $51,750.00 | 41.86% | View Filing |